A Randomized Double-Blind Placebo-Control Feasibility Trial of Immunoglobulin Treatment for Prevention of Recurrent Acute Exacerbations of COPD

BACKGROUND: Observational studies suggest that immunoglobulin treatment may reduce the frequency of acute exacerbations of COPD (AECOPD). OBJECTIVE: To inform the design of a future randomised control trial (RCT) of intravenous immunoglobulin (IVIG) treatment efficacy for AECOPD prevention. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Cowan, Juthaporn, Mulpuru, Sunita, Abdallah, Sara J, Chopra, Anchal, Purssell, Andrew, McGuinty, Michaeline, Alvarez, Gonzalo G, Giulivi, Antonio, Corrales-Medina, Vicente, MacFadden, Derek, Boyle, Loree, Hasimja, Delvina, Thavorn, Kednapa, Mallick, Ranjeeta, Aaron, Shawn D, Cameron, D William
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Clinical Trial Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650772/
https://www.ncbi.nlm.nih.gov/pubmed/34887657
http://dx.doi.org/10.2147/COPD.S338849

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8650772/
https://www.ncbi.nlm.nih.gov/pubmed/34887657
http://dx.doi.org/10.2147/COPD.S338849

Ejemplares similares